Janney Montgomery Scott
TCRT icon

Janney Montgomery Scott’s Alaunos Therapeutics TCRT Stock Holding History

Janney Montgomery Scott’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-278
Closed -$3K – 2829
2023
Q4 		$3K Sell
278
-168
-38% -$2.02K ﹤0.01% 2619
2023
Q3 		$9K Sell
446
-9
-2% -$388 ﹤0.01% 2545
2023
Q2 		$35K Sell
455
-56
-11% -$4.53K ﹤0.01% 2606
2023
Q1 		$48K Hold
511
– – ﹤0.01% 2409
2022
Q4 		$50K Sell
511
-3
-0.6% -$435 ﹤0.01% 2512
2022
Q3 		$133K Sell
514
-35
-6% -$10.2K ﹤0.01% 2370
2022
Q2 		$101K Sell
549
-14
-2% -$1.34K ﹤0.01% 2240
2022
Q1 		$55K Sell
563
-1
-0.2% -$128 ﹤0.01% 2209
2021
Q4 		$92K Sell
564
-15
-3% -$3.3K ﹤0.01% 2318
2021
Q3 		$158K Hold
579
– – ﹤0.01% 2195
2021
Q2 		$229K Buy
579
+9
+2% +$4.2K ﹤0.01% 2067
2021
Q1 		$308K Sell
570
-15
-3% -$9.34K ﹤0.01% 1843
2020
Q4 		$221K Sell
585
-158
-21% -$62.8K ﹤0.01% 2051
2020
Q3 		$281K Buy
743
+61
+9% +$26.9K ﹤0.01% 1738
2020
Q2 		$335K Sell
682
-113
-14% -$50.4K ﹤0.01% 1570
2020
Q1 		$292K Sell
795
-5
-0.6% -$2.59K ﹤0.01% 1497
2019
Q4 		$566K Buy
800
+129
+19% +$88.8K ﹤0.01% 1366
2019
Q3 		$431K Buy
671
+65
+11% +$51.6K ﹤0.01% 1474
2019
Q2 		$530K Buy
606
+60
+11% +$41.3K ﹤0.01% 1401
2019
Q1 		$315K Buy
546
+7
+1% +$2.93K ﹤0.01% 1641
2018
Q4 		$151K Sell
539
-5
-0.9% -$1.98K ﹤0.01% 1819
2018
Q3 		$261K Sell
544
-314
-37% -$135K ﹤0.01% 1792
2018
Q2 		$389K Buy
858
+3
+0.4% +$1.9K ﹤0.01% 1523
2018
Q1 		$502K Sell
855
-51
-6% -$31.8K 0.01% 1335
2017
Q4 		$563K Sell
906
-605
-40% -$435K 0.01% 1245
2017
Q3 		$1.39M Sell
1,511
-80
-5% -$71.1K 0.02% 772
2017
Q2 		$1.48M Sell
1,591
-185
-10% -$181K 0.02% 691
2017
Q1 		$1.69M Buy
1,776
+104
+6% +$96.8K 0.02% 625
2016
Q4 		$1.34M Sell
1,672
-193
-10% -$174K 0.02% 652
2016
Q3 		$1.57M Buy
+1,865
New +$1.5M 0.03% 512
2016
Q2 		– Sell
-2,255
Closed -$2.51M – 1119
2016
Q1 		$2.51M Buy
2,255
+429
+23% +$439K 0.07% 280
2015
Q4 		$2.28M Sell
1,826
-99
-5% -$164K 0.06% 312
2015
Q3 		$2.6M Buy
1,925
+118
+7% +$195K 0.07% 282
2015
Q2 		$3.25M Buy
1,807
+232
+15% +$360K 0.07% 348
2015
Q1 		$2.54M Sell
1,575
-799
-34% -$1.18M 0.05% 476
2014
Q4 		$1.81M Buy
2,374
+161
+7% +$85.5K 0.04% 595
2014
Q3 		$876K Sell
2,213
-140
-6% -$67.5K 0.02% 909
2014
Q2 		$1.42M Buy
2,353
+81
+4% +$45.1K 0.03% 650
2014
Q1 		$1.56M Buy
2,272
+35
+2% +$23.4K 0.04% 558
2013
Q4 		$1.46M Buy
2,237
+409
+22% +$244K 0.04% 562
2013
Q3 		$1.08M Buy
1,828
+1,270
+228% +$572K 0.03% 622
2013
Q2 		$177K Buy
+558
New +$155K 0.02% 708

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Janney Montgomery Scott's TCRT Position: Q1 2024 in Review

Janney Montgomery Scott sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 278 shares — an estimated $3K sold.

Janney Montgomery Scott first reported a position in TCRT in Q2 2013 and held it in 42 quarters. The position peaked at $3.25M in Q2 2015. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Janney Montgomery Scott reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 278 Alaunos Therapeutics shares in Q1 2024, an estimated $3K.
  • Janney Montgomery Scott first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 42 quarters.
  • Janney Montgomery Scott's Alaunos Therapeutics position peaked at $3.25M in Q2 2015.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Janney Montgomery Scott's 13F filing for Q1 2024, filed 1 May 2024.